Search Results 1-10 of 9479 for decrease distributed program

  1. Fenfluramine (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only under a restricted distribution program called Fintepla® REMS (Risk Evaluation and Mitigation Strategy Program. Back to top ...

  2. Neurology - Clinical trials - Mayo Clinic

    ... distributed brain activity. Advanced Care ... Reducing Neurocognitive Decline in Patients With Brain Metastases ... Businesses · Executive Health Program.

  3. Natalizumab-sztn (intravenous route) - Side effects & uses - Mayo Clinic

    ... decrease the number of relapses of the disease. ... This medicine is available only under a restricted distribution program called the Tyruko® REMS (Risk ...

  4. Phentermine and topiramate (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only under a special restricted distribution program called Qsymia® REMS program. This product is available in the following ...

  5. Macitentan and tadalafil (oral route) - Side effects & dosage - Mayo Clinic

    ... reduces the workload of the heart. This medicine is only available for female patients under a restricted distribution program called the Macitentan ...

  6. Ambrisentan (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only through a special restricted distribution program called the Letairis® REMS (Risk Evaluation and Mitigation Strategy) Program.

  7. Software - Tissue Repair and Mechanobiology laboratory - Mayo Clinic Research

    TractionsForAll v1.0 is a freely distributed program that calculates 2D tractions exerted by an adherent cell on its substrate. Dr. Tschumperlin's research team ...

  8. Iberdomide (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only under a restricted distribution program called the Zenbexus™ REMS (Risk Evaluation and Mitigation Strategy) program. This ...

  9. Lenalidomide (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only under a restricted distribution program called the Lenalidomide REMS (Risk Evaluation and Mitigation Strategy) program. This ...

  10. Gastroenterology and Hepatology - Clinical trials

    The primary aim of this study is to evaluate the distribution ... decrease inflammatory cytokines (11) and decrease ... Businesses · Executive Health Program.